ERIS LIFESCIENCES
Back to Balance Sheet
|
ERIS LIFESCIENCES Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹2,609 Cr | ₹521 Cr | ₹283 Cr | ₹235 Cr | ₹220 Cr |
What is the latest Total Current Liabilities ratio of ERIS LIFESCIENCES ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹2,609 Cr |
Mar2023 | ₹521 Cr |
Mar2022 | ₹283 Cr |
Mar2021 | ₹235 Cr |
Mar2020 | ₹220 Cr |
How is Total Current Liabilities of ERIS LIFESCIENCES Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,609 Cr | 400.58 | |
Mar2023 | ₹521 Cr | 83.94 | |
Mar2022 | ₹283 Cr | 20.34 | |
Mar2021 | ₹235 Cr | 6.94 | |
Mar2020 | ₹220 Cr | - |
Compare Total Current Liabilities of peers of ERIS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ERIS LIFESCIENCES | ₹17,020.0 Cr | -11.1% | -3.2% | 45.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,003.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,939.0 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
CIPLA | ₹117,835.0 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,787.0 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹90,722.1 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics |
ERIS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ERIS LIFESCIENCES | -11.1% |
-3.2% |
45.9% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses